Table 1.
Study subjects and characteristics
Characteristics | Controls | COPD | ||
---|---|---|---|---|
Number of subjects | 8 | 7 | ||
Age (range) | 60 | (43–70) | 62 | (53–66) |
Pack years (range) | 20 | (12–48) | 41 | (14–47) |
Gender, M/F in % | 50/50 | 58/42 | ||
FEV1% predicted | 98 | (89–132) | 61 | (41–70) |
Data in the Table are median values, with range given in parentheses. FEV1; % predicted = forced expiratory volume in 1 s expressed as a percentage of the predicted value. COPD patients were on maintenance treatment with inhaled glucocorticosteroids and long-acting β-agonist treatment, Symbicort®.